跳至主要内容
临床试验/CTRI/2018/03/012367
CTRI/2018/03/012367已完成1 期

Tolerability and efficacy of moderately high dose Turmacin supplementation on joint discomfort among healthy volunteers â?? open label single arm pilot study

atural Remedies Private Limited0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.All consenting adults aged between 18 and 65 years judged by Investigator to be in general good health on the basis of medical history
  • 2.No knee joint discomfort/pain at rest;
  • 3.Must achieve a knee joint discomfort/pain score of at least >= 40 mm on visual analogue scale (VAS) for pain after 10 minutes of brisk walk on the stepmill equipment.

排除标准

  • 1.Subjects having liver problems (raised ALT, AST), Heart (abnormal ECG / ECHO), kidney problems (raised creatinine), other muscle related problems (raised creatine kinase).
  • 2.Subjects having neurological disorders
  • 3.BMI greater than 32 kg/m2
  • 4.Taking concomitant medication like pain relievers or complements/ multivitamin supplements/ phytotherapeutical products that interfere with the product or outcomes of the study.
  • 5.Suffering from any kind of arthritic condition viz., autoimmune, infectious in the knee that could mislead the evaluation.
  • 6.Having trauma or surgery histories that have affected the knee.
  • 7.Having a disease that results in bad intestinal absorption
  • 8.Women of child bearing age who do not wish to use approved birth control methods during study
  • 9.Being pregnant or breastfeeding.
  • 10.Allergic or hypersensitive to turmeric
  • 11.Being participating or having participated in a clinical assay or intervention study within the previous 30 days before inclusion in the study
  • 12.Being unable to follow the guidelines of the study

研究者

发起方
atural Remedies Private Limited

相似试验

Benefits and harms of using moderately high dose... | 临床试验